Red Blood Cell
Showing 9976 - 10000 of >10,000
Large B-cell Lymphoma Trial in Shanghai (BZ019)
Recruiting
- Large B-cell Lymphoma
- BZ019
-
Shanghai, Shanghai, ChinaShanghai Mengchao Cancer Hospital
Jul 21, 2022
Peripheral Artery Disease Trial in Omaha (Supervised exercise therapy)
Not yet recruiting
- Peripheral Artery Disease
- Supervised exercise therapy
-
Omaha, NebraskaOmaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Aug 24, 2023
Large B-cell Lymphoma Trial in Groningen (89Zr-atezolizumab PET-imaging)
Recruiting
- Large B-cell Lymphoma
- 89Zr-atezolizumab PET-imaging
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 15, 2022
Treatment Side Effects Trial (the Mandarin Version of the electronic patient self-Reporting of Adverse-events (eRAPID-MV), the
Not yet recruiting
- Treatment Side Effects
- the Mandarin Version of the electronic patient self-Reporting of Adverse-events (eRAPID-MV)
- the telephone triage decision support system (TTDSS)
- (no location specified)
Aug 9, 2022
Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)
Not yet recruiting
- Advanced Solid Tumors Cancer
- +3 more
-
New York, New YorkMemorial Slone Kettering Cancer Center
Jun 26, 2023
Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)
Recruiting
- Metastatic Squamous Non-Small Cell Lung Carcinoma
- Cabozantinib 40 MG
- Pembrolizumab 200mg
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jan 20, 2023
Ridge Splitting Trial in Mansoura (ridge splitting with implant placement)
Completed
- Ridge Splitting
- ridge splitting with implant placement
-
Mansoura, Dakahlia, EgyptMarwa Adel
Apr 19, 2023
Sickle Cell Disease Trial in Afula (Memantine Hydrochloride)
Unknown status
- Sickle Cell Disease
- Memantine Hydrochloride
-
Afula, IsraelEmek Medical Centre
Oct 30, 2019
Esophageal Cancer in Northeastern Iran
Active, not recruiting
- Esophageal Cancer
- GI Disease
-
Tehran, Iran, Islamic Republic ofDigestive Disease Research Institute
Aug 18, 2022
The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT Trial (CD25
Not yet recruiting
- The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT
- CD25 prophylaxis
- (no location specified)
Jun 20, 2023
Brain Neuronal Networks, Chemosensory and Trigeminal Functions
Recruiting
- Hematopoietic Stem Cell Transplantation
-
Oslo, NorwayUniversity of Oslo
Aug 21, 2023
Type 1 Diabetes Trial in Stanford, Aurora, Charlottesville (Tandem t:slim X2 with Control-IQ Technology Pro, Standard Care (SC),
Completed
- Type 1 Diabetes
- Tandem t:slim X2 with Control-IQ Technology Pro
- +2 more
-
Stanford, California
- +2 more
Oct 7, 2022
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Portland (Ibrutinib, Obinutuzumab)
Completed
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Ibrutinib
- Obinutuzumab
-
Portland, OregonOHSU Knight Cancer Institute
Dec 10, 2021
Aging Trial in Boulder (MitoQ, Placebo)
Recruiting
- Aging
- MitoQ
- Placebo
-
Boulder, ColoradoUniversity of Colorado Boulder
Jul 20, 2022
Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)
Completed
- Tuberculosis, Multidrug-Resistant
-
Beijing, China
- +7 more
Sep 30, 2021
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)
Recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Vancouver, British Columbia, Canada
- +31 more
Jan 17, 2023
Repeat Immunoadsorption Post Covid ME/CFS
Recruiting
- Post-COVID ME/CFS
- IA with TheraSorb ® column
-
Berlin, GermanyCharité - Universitätsmedizin Berlin
Nov 21, 2022
miRNAs Associated With Gender Difference in Osteoarthritis
Recruiting
- Osteoarthritis
- No intervention
-
Bagheria, Palermo, ItalyDipartimento Rizzoli Sicilia - Istituto Ortopedico Rizzoli
Aug 31, 2022
Metastatic Renal Cell Carcinoma, Metastatic Urothelial Carcinoma Trial in New York (Nivolumab, Atezolizumab, Radiation &
Terminated
- Metastatic Renal Cell Carcinoma
- Metastatic Urothelial Carcinoma
- Nivolumab
- +3 more
-
New York, New YorkWeill Cornell Medicine - New York Presbyterian Hospital
Aug 26, 2021
Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)
Active, not recruiting
- Non Small Cell Lung Cancer
-
Santiago De Compostela, A Coruña, Spain
- +29 more
Sep 21, 2022
Combat Injury on Sleep and Cardiovascular Outcomes
Not yet recruiting
- Hypertension
- +5 more
- (no location specified)
Jul 24, 2023
MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)
Recruiting
- Myelodysplastic Syndromes
- Unrelated Umbilical Cord Blood
- +3 more
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Oct 27, 2023
Healthy Aging Trial in Reading (Watermelon Juice, Water)
Active, not recruiting
- Healthy Aging
- Watermelon Juice
- Water
-
Reading, UK, United KingdomUniversity of Reading
Nov 15, 2022